Commentary

Steps to optimizing skin care retail in your practice


 

References

• Sell skin care products in your practice.

I was against selling skin care products for ethical reasons for several years. However, in 2005, I surveyed my patients, and 100% of them wanted me to sell products so that they could feel sure that they were purchasing the right products for their needs. In fact, my patients appreciate expert medical advice on skin care. As a practitioner, you can make more educated choices about skin care products and help them avoid products that don’t work or cause harm.

• Contact me for more information.

In order to improve patient outcomes, you must ensure that you stay current on skin care science so your patients can benefit from your expertise. I recognize that not everyone has the time and inclination to stay current on the various skin care ingredients, products, and brands. Several of my dermatology friends have adopted my skin typing system in their practices and, in the process, observed better patient outcomes and increased profitability, while reducing the burden on their staff. These successes led to the development of an in-office store system utilizing my concept, which I am offering only to dermatologists. Feel free to email me at DrB@derm.net, or visit STSFranchise.com, if you want to learn more.

• Look for this column each month.

I will be sharing more advice on in-office skin care retail and will continue my review of new cosmeceutical ingredients. Let’s work together to put skin care back in the hands of dermatologists.

Dr. Baumann is chief executive officer of the Baumann Cosmetic & Research Institute in Miami Beach. She founded the cosmetic dermatology center at the University of Miami in 1997. Dr. Baumann wrote the textbook "Cosmetic Dermatology: Principles and Practice" (McGraw-Hill, April 2002), and a book for consumers, "The Skin Type Solution" (Bantam, 2006). She has contributed to the Cosmeceutical Critique column in Skin & Allergy News since January 2001. Dr. Baumann has received funding for clinical grants from Allergan, Aveeno, Avon Products, Galderma, Mary Kay, Medicis Pharmaceuticals, Neutrogena, Philosophy, Stiefel, Topix Pharmaceuticals, and Unilever.

Pages

Recommended Reading

Verrucous Cobblestonelike Papules and Nodules of the Right Lower Limb
MDedge Dermatology
Experts disagree on skin endpoint in psoriatic arthritis
MDedge Dermatology
ICD-10: Dual coding is only for testing, claims backlog
MDedge Dermatology
A New Appraisal of Dermatologic Manifestations of Diabetes Mellitus
MDedge Dermatology
Patients become full partners in inflammatory arthritis and psoriasis research
MDedge Dermatology
Mayo Clinic tops hospital rankings for 2014-2015
MDedge Dermatology
Treatment of Actinic Keratosis With Picato® (ingenol mebutate) Gel – A New Supplement
MDedge Dermatology
A teen-focused STD prevention program reduced gonorrhea incidence
MDedge Dermatology
HIPAA: One last deadline looms
MDedge Dermatology
Axial involvement found common in psoriatic arthritis mutilans
MDedge Dermatology